Shearman & Sterling represented Morgan Stanley Senior Funding, Inc. and HSBC Securities (USA) Inc. as joint lead arrangers, joint bookrunners and co-syndication agents of a $310 million first lien and $140 million second lien financing for Alkermes, Inc. in connection with its acquisition of Elan Drug Technologies, a unit of Elan Corporation, plc.

The Shearman & Sterling team included partners Maura O'Sullivan (New York-Finance), Don Lonczak (Washington, DC-Tax) and Tina Patel (Palo Alto-Intellectual Property Transactions); counsel Sharon Lippett (New York-Executive Compensation & Employee Benefits); and associates Ada Ho (New York-Finance), Jennifer M. Pacella (New York-Finance), Gary Tashjian (New York-Finance) and Sanjay Thapar (New York-Finance).